Redefining non-invasive cancer treatment
Replacing chemo drugs with nanoparticle technology
Weekly production has doubled since May
Acquired Varian for $16.4 billion in early 2021
Noninvasively ablates cancerous liver tissue
Study finds 98.6 percent cure rate at five years
Radioisotopes' half-lives make them perishable
New research unveiled at SNMMI meeting
Publication aimed at helping patients make informed decisions.
Stance on pre-surgical radiation still pending
Mirion Medical Brands Present Solution Together at 2023 RSNA Annual Meeting
Damaging cancer DNA while immune system homes in on tumor cells
An editorial by Sal Martino, CEO of ASRT
Designed to replace conventional radiotherapy systems
The biggest MR stories of the year from our Daily News online
Q&A with ASTRO president Dr. Laura Dawson